Blog

Frances Oldham Kelsey: Biyografi, Başarılar ve Kalıcı Miras

Frances Kathleen Oldham Kelsey (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American pharmacologist and physician who had a 45-year career with the U.S. Food and Drug Administration (FDA). As a reviewer, she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects. Kelsey's career intersected with the passage of laws strengthening FDA oversight of pharmaceuticals. Kelsey was the first woman to receive a PhD in pharmacology and the second woman to receive the President's Award for Distinguished Federal Civilian Service, awarded to her by John F. Kennedy in 1962.

Temel Bilgiler

Miras ve Etki

The influence of Frances Oldham Kelsey extends far beyond her own lifetime. She fundamentally shaped healthcare and human longevity, and her medical discoveries and treatments remain foundational to this day.

Though she passed away in 2015, her ideas continue to be studied, debated, and built upon by scholars and practitioners worldwide.

Frances Oldham Kelsey, Canada'in yetiştirdiği en saygın zekâlardan biri olmaya devam ediyor; bu, bölgenin zengin entelektüel mirasının kanıtıdır.

Canada'dan tanınmış dahiler

Canada, pek çok dikkat çekici zekâ yetiştirmiştir. Frances Oldham Kelsey'in yanı sıra:

Canada'dan tüm dahileri gör →

Medicine alanındaki daha fazla parlak zekâyı keşfedin

Keşfet Medicine Geniuses

Daha Fazla

Frances Oldham Kelsey hakkında tam profili okuyun

Frances Oldham Kelsey profilini görüntüle →

Daha fazla dahi keşfedin

1,300+ articles · 1,300+ biographies · Türkçe

Hepsini gör